Area postrema glutamate receptors mediate respiratory and gastric responses in the rabbit. by Bongianni, Fulvia et al.
Introduction
The area postrema (AP) receives significant visceral
(vagal, glossopharyngeal) afferent projections and 
has extensive connections with other regions of the
central nervous system1–3 involved in the control of
respiration and gastric motility. The primary func-
tion attributed to the AP has been that of a chemo-
ceptive trigger zone for emesis.4 However, this region
has been implicated in various other physiological
functions, such as arousal, control of caloric and fluid
homeostasis and cardiovascular regulation.4 Recently,
we have provided evidence that the AP is involved
in the control of both respiration and gastric motility;
microinjections of DL-homocysteic acid (DLH), 
the broad-spectrum excitatory amino acid (EAA)
agonist, provoked marked excitatory effects on
respiration associated with gastric relaxation.5,6 EAAs 
are believed to mediate much of the fast excitatory
synaptic transmission within the central nervous
system by acting on ionotropic receptors, i.e. NMDA
and non-NMDA or AMPA/kainate receptors.7
The purpose of this study was twofold. The first
purpose was to extend our previous finding by
determining whether both NMDA and non-NMDA
receptors are involved in mediating DLH-induced
respiratory and gastric responses. The second pur-
pose was to ascertain whether ionotropic EAA
receptors have a role in mediating tonic influences of
AP neurones on both respiratory activity and gastric
motility by making use of selective antagonists.
Materials and Methods
Experiments were carried out on 18 male New
Zealand white rabbits (2.7–3.2 kg) anaesthetized 
with a mixture of a-chloralose (40 mg kg–1, i.v.; 
Sigma Chemical, St. Louis, MO, USA) and urethane
(800 mg kg–1, i.v.), supplemented when necessary 
(4 mg kg–1 and 80 mg kg–1, respectively). The state of
the pupil (constriction) and the absence of reflex
withdrawal of the hindlimbs to nociceptive stimuli
ensured full surgical anaesthesia. All animal care and
experimental procedures were conducted in accor-
dance with the Italian legislation and the official
regulations of the European Communities Council
on use of laboratory animals.
Following cannulation of the trachea, polyethylene
catheters were inserted into a femoral artery and 
vein for recording of arterial blood pressure and sys-
temic administration of drugs, respectively. Both C5
phrenic roots were dissected free, cut distally and
prepared for recordings. Both cervical vagus nerves
were separated from the sympathetic trunks for
subsequent vagotomy. The animal was placed in 
a prone position and fixed by a stereotaxic head
holder and vertebral clamps. The medulla was 
widely exposed by occipital craniotomy. Body temp-
erature was maintained at 38 ± 0.5° C by a heating
blanket controlled through a rectal thermistor probe.
The animals were generally spontaneously breathing;
however, during the course of the experiment 
some of them (n = 10) were bilaterally vagotomized,
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THE role of NMDA and non-NMDA receptors of the
area postrema (AP) in the control of respiration and
gastric motility was investigated in anaesthetized rabbits
using microinjections (10–20 nl) of specific agonists or
antagonists. NMDA (20 mM) or AMPA (10 mM) caused
excitatory effects on respiration and gastric relaxation.
Selective blockade of NMDA or non-NMDA receptors,
respectively with D(–)-2-amino-5-phosphonopentanoic
acid (D-AP5; 10 mM) and 6-nitro-7-sulphamoyl-
benzo(f)quinoxaline-2,3-dione (NBQX; 5 mM), decreased
respiratory frequency and increased gastric tone. Both
these effects were more marked following non-NMDA
receptor blockade and were prevented by vagotomy.
These findings show that NMDA and non-NMDA
receptors are present on AP neurones and have a role
in the tonic control of respiration and gastric motility.
NeuroReport 9: 2057–2062 © 1998 Rapid Science Ltd.
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paralysed (gallamine triethiodide 4 mg kg–1, i.v.,
supplemented with 2 mg kg–1 every 30 min, Sigma)
and artificially ventilated. In paralysed preparations,
the adequacy of anaesthesia was assessed by the
absence of fluctuations in arterial blood pressure or
phrenic nerve activity, whether spontaneous or in
response to somatic nociceptive stimuli. 
Efferent phrenic nerve activity was recorded from
desheathed C5 phrenic roots using bipolar platinum
electrodes, amplified, full-wave rectified and inte-
grated (low-pass filter, time constant 100 ms). Mean
arterial blood pressure (MAP) was recorded by a
strain gauge manometer. End-tidal CO2 was moni-
tored by means of an infrared CO2 analyser (Datex
CD-102, Normocap, Helsinki, Finland). In artifi-
cially ventilated animals, end-tidal CO2 was kept at
desired levels (4–5%) by adjusting the frequency and
stroke volume of the respiratory pump. Gastric
motility was recorded by means of a large flaccid
(rubber) balloon passed down the oesophagus into
the stomach, according to a technique described
previously.8 The balloon was filled with warm water
(38 ° C) and connected to a wide diameter reservoir.
Gastric motility was recorded isotonically9 with a
strain gauge manometer connected to the reservoir.
Basal gastric volume was set at ~65 ml by elevating
the reservoir and causing an influx of fluid into the
balloon (load 5–7 cm of water). The signals of all
variables studied were continuously monitored on 
an 8-channel rectilinearly writing chart recorder
(Model 8K20, NEC San-ei Instruments, Tokyo,
Japan). Microinjections (10–20 nl) of different EAA
receptor agonists and antagonists were made into 
the AP at appropriate depths (150–300 mm). The
following drugs (Tocris Cookson, Bristol, UK) 
were used: NMDA (20 mM), AMPA (10 mM), the 
NMDA receptor antagonist D(–)-2-amino-5-phos-
phonopentanoic acid (D-AP5; 10 mM) and the 
non-NMDA receptor antagonist 6-nitro-7-sulpha-
moylbenzo(f)quinoxaline-2,3-dione (NBQX; 5 mM).
Agonist concentrations were selected in prelimi-
nary trials in order to consistently obtain effects on
respiratory and gastric motility similar to those
previously reported with 160 mM DLH microinjec-
tions into the AP.5 Antagonist concentrations were
in the same range of those reported to be effective
and selective in blocking EAA transmission in 
the medulla of in vivo preparations.10 In addition, the
effectiveness of EAA receptor blockade was deter-
mined empirically: 20 mM NMDA or 10 mM AMPA
was completely ineffective when injected into the 
AP 3–5 min following a microinjection at the 
same site as 10 mM D-AP5 (n = 2) or 5 mM NBQX
(n = 3), respectively. The drugs were dissolved in
0.9% NaCl solution containing in most experiments
0.1–0.2% Pontamine sky blue to mark the injection
site; the pH was adjusted to 7.4 with 0.1 N NaOH.
The injections were performed via a glass micro-
pipette (tip diameter 10–25 mm) by applying pressure
using an air-filled syringe connected to the micro-
pipette by polyethylene tubing. The volume of the
injectate was measured directly by monitoring 
the movement of the fluid meniscus in the pipette
barrel with a dissecting microscope equipped with a
fine reticule. The time taken to inject the solution
ranged from 5 to 10 s. Control injections of equal
volumes of vehicle solutions were also performed. 
At the end of the experiment the brain was
removed and fixed in 10% formol saline. Frozen
coronal sections (20 mm) stained with cresyl violet
were used for the histological control of pipette tracks
and injection sites. The atlas of Shek et al.11 was used
for comparison.
The respiratory frequency (breaths min–1), inspi-
ratory time, expiratory time and peak amplitude of
the integrated phrenic nerve activity (arbitrary units)
were measured on paper recordings (usual paper
speed 2 mm s–1; 10 mm s–1 for expanded traces). When
a level of tonic phrenic activity developed in response
to chemical stimulation (see Results), it was included
in the measurement of peak phrenic amplitude.
Respiratory variables were measured  for an average
of five consecutive breaths both in the period imme-
diately preceding each trial and at the time when the
maximum response to injected drugs occurred (see
Results). Gastric volume and MAP were measured 
at 2 s intervals for 20 s and averaged both during
control periods and during maximum responses to
drug application. Owing to the small variations in
the studied variables within a measurement period,
the average value for each period was taken as a single
measurement for purpose of analysis. Statistical
analysis of data was performed using Wilcoxon
signed rank tests or Mann-Whitney tests. All values
are presented as means ± s.e.; p < 0.05 was considered
as significant. 
Results
The respiratory responses to microinjections (10–
20 nl) of 20 mM NMDA (0.2–0.4 nmol) and 10 mM
AMPA (0.1–0.2 nmol) into the AP (mid-line or just
lateral to the mid-line, > 0.6 mm caudal to the rostral
margin of the AP at 150–300 mm depth) mainly
consisted of a progressive and marked increase in
respiratory frequency, usually associated with the
development of tonic phrenic activity without any
significant change in peak phrenic amplitude (Fig. 1).
In both cases the onset of the responses was rela-
tively rapid (10–30 s from the start of the injection);
the maximum response occurred within 50–120 s,
while a complete recovery was usually observed after
F. Bongianni et al.
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30–40 min. After NMDA microinjections, the
respiratory frequency showed a mean increase of 
88.3 ± 17.5% (range 50–160%) rising from baseline 
values of 42.5 ± 1.6 to 79.5 ± 7.8 breaths min–1
(n = 6; p < 0.05). After AMPA microinjections the
respiratory frequency increased by 92.1 ± 9.7%
(range 65.2–126.6%) rising from 41.5 ± 1.7 to 80.1
± 4.5 breaths min–1 (n = 6; p < 0.05). These excitatory
effects on phrenic nerve activity were accompanied
or, more often, preceded by an obvious gastric
relaxation (Fig. 1). The onset of the gastric relaxation
was rapid (5–20 s from the start of the injection); 
the maximum response in gastric motility occurred
within 30–140 s, while recovery followed a time
course similar to that of respiratory effects. The
magnitudes of gastric responses were 3.1 ± 0.5 ml
(range 2–5 ml) after NMDA microinjections (n = 6;
p < 0.05) and 3.2 ± 0.7 ml (range 2–6.5 ml) after
AMPA microinjections (n = 6; p < 0.05). The effects
on phrenic nerve activity and gastric motility 
were associated with small but significant increases
(p always < 0.05) in MAP of 9.2 ± 3.8 mmHg and 
12.7 ± 2.6 mmHg for NMDA and AMPA, respec-
tively.
Microinjections (10–20 nl) of both 10 mM D-AP5
(0.1–0.2 nmol) and 5 mM NBQX (0.05–0.1 nmol)
caused respiratory depression and increases in gastric
tone (Fig. 2). The respiratory frequency showed a
mean decrease of 11.5 ± 1.7% (from 45.3 ± 1.8 to 
40.8 ± 2.1 breaths min–1) after D-AP5 microinjections 
(n = 9, p < 0.005) and of 21.3 ± 1.9% (from 43.1 ± 1.8
to 34.1 ± 1.2 breaths min–1) after NBQX micro-
injections (n = 9, p < 0.005). These decreases were
mainly due to an increase in the expiratory time. 
Peak phrenic amplitude did not vary significantly.
These respiratory effects were accompanied by a mild
increase in gastric tone. Gastric volume showed a
mean decrease of 1.9 ± 0.4 ml (range 0.5–3 ml) after
D-AP5 microinjections (n = 9, p < 0.005) and of 
4.1 ± 0.7 ml (range 2–9 ml) after NBQX microinjec-
tions (n = 9, p < 0.005). Both respiratory and gastric
responses were more marked in response to NBQX
microinjections (p < 0.05). Both effects showed a
rapid onset (10–40 s from the start of the injection)
and attained the maximum within 1–4 min; complete
recovery occurred after 15–20 min. No changes in
MAP were observed. Microinjections of either 
10 mM D-AP5 (n = 4) or 5 mM NBQX (n = 6) into
the AP, performed at the same sites after bilateral
vagotomy, failed to induce both gastric and respira-
tory responses. The effects of agonist and antagonist
microinjections were reproducible both within and
between animals; however, to obtain the same res-
ponse at the same site it was necessary to wait at least
40 min for agonist microinjections and 60 min for
antagonist microinjections. Control microinjections
of equivalent volumes of the vehicle solution
performed at the same locations did not induce any
appreciable effect. Representative sites of microinjec-
tions of both EAA receptor agonists and antagonists
are shown diagrammatically in Fig. 3.
Discussion
The effects obtained with microinjections of EAA
receptor agonists indicate that both NMDA and non-
NMDA ionotropic receptors are present on neurones
located in the AP and that their activation has a role
in the mediation of DLH-induced respiratory and
gastric responses.5,6 The presence of both NMDA and
non-NMDA receptors on the same neurones is
common in other areas of the central nervous system,
such as, for instance, the nucleus tractus solitarii
(NTS);7,12–14 it may reflect a mechanism modulating
the strength of AP respiratory and gastric responses
to appropriate excitatory inputs. In fact, at normal
resting membrane potentials, activation of NMDA
receptors is prevented by physiological concentra-
tions of Mg2+. However, this block is voltage depen-
dent and decreases as a neurone is depolarized.7,15
Area postrema glutamate receptors
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FIG. 1. Effects on integrated phrenic nerve activity (IPA), gastric
volume (GV) and mean arterial blood pressure (MAP) in response
to microinjections (15 nl) of 20 mM NMDA (A) and 10 mM AMPA
(B) into the AP. Left panels, control and effects immediately following
the injection (filled bar). Right panels, recovery 30 min after the
injection.
Thus, under conditions of sufficient depolarization,
activation of NMDA receptors may modulate AP
neuronal responses. 
In agreement with our previous results,5 the acti-
vation of both NMDA and non-NMDA receptors
caused small but consistent increases in blood pres-
sure (Fig. 1), thus confirming that the AP may play
a role in cardiovascular regulation.4 However, the
absence of significant cardiovascular responses in
vagotomized animals to DLH microinjections5,6 leads
us to propose an interpretation similar to that
suggested for DLH-induced effects,5 i.e. that the
small pressor responses observed in this study are, to
a great extent, secondary to mechanical changes due
to increased respiratory activity. Nevertheless, this
does not completely rule out a role of vagus nerves
in their modulation.
More interestingly, present results show that AP
neurones exert tonic influences on both respiration
and gastric motility via EAA receptors, with a larger
involvement of non-NMDA receptors (Fig. 2). This
result cannot be attributed to a failure to adequately
block NMDA receptors in the AP, because both
gastric and respiratory responses evoked by NMDA
were virtually eliminated after D-AP5 administration
(see Materials and Methods). The major role played
by the non-NMDA receptors implies a more effective
transmission of synaptic inputs through this type of
F. Bongianni et al.
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FIG. 2. Decreases in respiratory frequency and increases in gastric tone induced by 10 mM D-AP5 or 5 mM NBQX microinjected into the
AP. Mean changes are illustrated by bar diagrams in (A) and (C), respectively. Reported values are means ± s.e; *p < 0.005. Examples of the
effects on integrated phrenic nerve activity (IPA) 2 min after a microinjection (15 nl) of each type of EAA receptor antagonist are reported
in (B). Examples of changes in gastric volume (GV) in response to a microinjection (15 nl) of D-AP5 or NBQX (filled bars) are reported in
(D).
receptors. This is consistent with the presence of the
already mentioned voltage-sensitive Mg2+ blockade 
of NMDA receptor channels.7,15
The effects observed with both D-AP5 and NBQX
microinjections suggest that AP cells receive an
excitatory input probably via glutamate. Some of 
this excitation may arise from other areas of the
central nervous system;1–3 however, the effects of
bilateral vagotomy indicate that tonic influences 
of AP neurones are maintained by vagal afferent
inputs. This is certainly true for respiratory activity,
but it can only be hypothesized for gastric motility
since vagotomy also affect efferent fibres to the
stomach.
Central afferent projections of the vagus nerve
have as the principal target sites the NTS and the
adjacent AP; these projections include those of
pulmonary, cardiac, gastrointestinal and barorecep-
tors afferents.1–3,16,17 At present, we can only specu-
late on the type of vagal receptors involved in 
these AP tonic influences; all three main types of
pulmonary receptors (slowly adapting stretch recep-
tors, rapidly adapting receptors and broncopul-
monary C-fibre receptors) may contribute.17 As to
the control of gastric tone, a primary role could be
played by mechanoreceptors in the muscle of the
oesophagus and gastric body; however, mechanore-
ceptors and chemoreceptors in the gastric antrum and
duodenum might also be involved.18
We have recently reported5,6 a complete discussion
on the microinjection technique used in the present
study. The complete recovery after drug application
as well as the absence of effects in response to
microinjections of equivalent or even larger volumes
of the vehicle solution indicate that the observed
responses are not due to toxicity or non-specific
effects of pressure and volume. 
Evidence has been provided that glutamate is 
the most likely candidate as the neurotransmitter
between some vagal primary afferent fibres and 
NTS neurones. These afferents include those arising
from slowly adapting pulmonary stretch receptors,12
broncopulmonary C-fibre endings19 and aortic baro-
receptors.20,21 On the other hand, glutamate is consid-
ered the best candidate as the excitatory transmitter
for other primary sensory afferents in the NTS13,22
as well as in other areas of the central nervous
system.7,13 Thus, since both NTS and AP share the
majority of vagal projections,1–3,16,17 it is conceivable
that glutamate may also be involved in the neuro-
transmission between some primary vagal afferents
and AP neurones.23
Conclusions
This study is the first to provide evidence that 
both NMDA and non-NMDA receptors are present
in the AP of the rabbit and that their activation
mediates excitatory respiratory responses and gastric
relaxation. More interestingly, the results show 
that AP neurones are involved in the tonic control
of respiration and gastric motility via both types of
ionotropic EAA receptors, with a major contribution
from non-NMDA receptors. Tonic AP influences on
respiration, and conceivably also those on gastric
tone, are mediated by the input conveyed by vagal
afferents.
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